Retraction Note to: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases: Meta-Analysis of Three Randomized, Controlled Trials

Jun Iwamoto, Hideo Matsumoto, Tsuyoshi Takeda

Research output: Contribution to journalArticle

Abstract

The Editor-in-Chief has retracted this article because two of the three studies [1, 2] included in the meta-analysis (cited as references 11 and 12) have been retracted due to fabrication of the data, which has rendered the results of this meta-analysis invalid.

Original languageEnglish
Number of pages1
JournalClinical Drug Investigation
DOIs
Publication statusAccepted/In press - 2018 Mar 26

Fingerprint

Vitamin K 2
Hip Fractures
Meta-Analysis
Randomized Controlled Trials
menatetrenone

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{69491a9ba2e44aaab6f9c1bb2ea2fc90,
title = "Retraction Note to: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases: Meta-Analysis of Three Randomized, Controlled Trials",
abstract = "The Editor-in-Chief has retracted this article because two of the three studies [1, 2] included in the meta-analysis (cited as references 11 and 12) have been retracted due to fabrication of the data, which has rendered the results of this meta-analysis invalid.",
author = "Jun Iwamoto and Hideo Matsumoto and Tsuyoshi Takeda",
year = "2018",
month = "3",
day = "26",
doi = "10.1007/s40261-018-0643-3",
language = "English",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Retraction Note to

T2 - Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases: Meta-Analysis of Three Randomized, Controlled Trials

AU - Iwamoto, Jun

AU - Matsumoto, Hideo

AU - Takeda, Tsuyoshi

PY - 2018/3/26

Y1 - 2018/3/26

N2 - The Editor-in-Chief has retracted this article because two of the three studies [1, 2] included in the meta-analysis (cited as references 11 and 12) have been retracted due to fabrication of the data, which has rendered the results of this meta-analysis invalid.

AB - The Editor-in-Chief has retracted this article because two of the three studies [1, 2] included in the meta-analysis (cited as references 11 and 12) have been retracted due to fabrication of the data, which has rendered the results of this meta-analysis invalid.

UR - http://www.scopus.com/inward/record.url?scp=85044477567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044477567&partnerID=8YFLogxK

U2 - 10.1007/s40261-018-0643-3

DO - 10.1007/s40261-018-0643-3

M3 - Article

C2 - 29705920

AN - SCOPUS:85044477567

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

ER -